Press Releases with tag "Regulatory Affairs"

FDA Approval Of Generic Version Of Cancer Drug Doxorubicin Hydrochloride Liposome Injection Is Expected To Help Resolve Shortage Of Drug Supply
i-Newswire, 2013-03-18
FDA approved generic version of cancer drug doxorubicin hydrochloride liposome which is used to treat patients with ovarian cancer and currently faced with shortage supply

SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
i-Newswire, 2013-02-08
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany.

Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., And Cytonet Set To Speak On Conducting Effective Orphan Drug Research
i-Newswire, 2012-11-15
Barbara Wuebbels, R.N., M.S., Oved Amitay, and Rod Monroy, Ph.D. set to speak at the Premier marcus evans Life Cycle of Orphan Drug Development & Commercialization Conference

Monitoring the Safety of Post-Market Medical Devices
i-Newswire, 2012-10-17
Interview with Tatyana Chorny, Regulatory Affairs, Post-Market Surveillance & Complaints Management at Philips Healthcare

SFL’s Managing Director and Head of UK Office to Speak at DIA Combination Products Workshop in Basel, Switzerland
i-Newswire, 2012-09-05
SFL to provide update on the latest revision of the European medical device and in-vitro diagnostics (IVD) legislation at one-day DIA Combination Products Workshop.

Synowledge Observes Rare Disease Day
i-Newswire, 2012-03-05
Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore

Former Global Regulatory Chief Laurie Smaldone, MD, Tapped as PharmApprove President
i-Newswire, 2011-09-16
Dr. Laurie Smaldone joins Princeton-based strategic regulatory communications firm, PharmApprove, as President

Advanced, Web Based, Live, Training Program for GCP & GXP Trainers Worldwide
i-Newswire, 2010-11-14
Educational Services Division of UK based MNC,Helix Research Center Ltd has announced 'Advanced Web Based,Live Training Program for GCP and GXP Trainers' conducting Training for Clinical Research and Healthcare Industries etc Worldwide